-
-
-
-
-
-
-
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301
-
-
-
-
-
-
-
Galapagos receives transparency notification from FMR LLC
-
-
-
-
-
-
-
Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
-
-
-
-
-
-
-
Galapagos NV (GLPG) announces Selvita to acquire Fidelta
-
-
-
-
-
-
-
Arrakis Therapeutics Appoints Katrine Bosley as Chairman of the Board of Directors
-
-
-
-
-
-
-
Gilead (GILD) Expands Collaboration with Galapagos (GLPG), Raises Stake to 22%
-
-
-
-
-
-
-
Galapagos NV (GLPG) announces launch of $300M proposed public offering of ADSs
-
1,186,417 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

